Relative efficiency of oral or parenteral routes for the antirachitic potency of cholecalciferol sulfoconjugate on chicks and rats.
D000284:Administration, Oral; D000818:Animals; D001842:Bone and Bones / Q000503:physiopathology; D002118:Calcium / Q000097:blood / Q000378:metabolism; D002762:Cholecalciferol / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007700:Kinetics; D051381:Rats; D012279:Rickets / Q000188:drug therapy* / Q000503:physiopathology
D002762:Cholecalciferol; D002118:Calcium